Blackstone approaches $2.4bn deal for Precision Medical Group

If a deal is reached, existing investors Berkshire Partners and TPG Growth are expected to remain minority investors in the provider of outsourced pharma services.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this